Literature DB >> 9475515

Evaluation of the role of P-glycoprotein in ivermectin uptake by primary cultures of bovine brain microvessel endothelial cells.

J M Rose1, S L Peckham, J L Scism, K L Audus.   

Abstract

The P-glycoprotein efflux system located on the apical membrane of brain capillary endothelial cells functions as part of the blood-brain barrier. In this study, primary cultures of bovine brain microvessel endothelial cells (BMECs) were investigated for the presence of a P-glycoprotein system and its contribution in regulating ivermectin distribution across the blood-brain barrier. Results of rhodamine 123 uptake studies with cyclosporin A and verapamil as substrates indicated that a functional efflux system was present on BMECs. Immunoblot analysis with the C219 monoclonal antibody to the product of the multidrug resistant member 1(MDR1) gene also confirmed the expression of MDR1 in the BMECs. Unbound ivermectin was shown to significantly increase the uptake of rhodamine 123 in BMECs, however, the drug only modestly enhanced the transcellular passage of rhodamine. The results of these studies affirmed that unbound ivermectin is an inhibitor of the MDR1 efflux system in BMECs.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9475515     DOI: 10.1023/a:1022485026198

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  26 in total

1.  Permeability of the blood-brain barrier to the immunosuppressive cyclic peptide cyclosporin A.

Authors:  D J Begley; L K Squires; B V Zloković; D M Mitrović; C C Hughes; P A Revest; J Greenwood
Journal:  J Neurochem       Date:  1990-10       Impact factor: 5.372

2.  Response to physostigmine administration in collie dogs exhibiting ivermectin toxicosis.

Authors:  W J Tranquilli; A J Paul; R L Seward; K S Todd; J A Dipietro
Journal:  J Vet Pharmacol Ther       Date:  1987-03       Impact factor: 1.786

3.  Pharmacokinetic studies of ivermectin: effects of formulation.

Authors:  P K Lo; D W Fink; J B Williams; J Blodinger
Journal:  Vet Res Commun       Date:  1985-09       Impact factor: 2.459

4.  Brain microvessel endothelial cells in tissue culture: a model for study of blood-brain barrier permeability.

Authors:  P D Bowman; S R Ennis; K E Rarey; A L Betz; G W Goldstein
Journal:  Ann Neurol       Date:  1983-10       Impact factor: 10.422

5.  Circumvention of vincristine and Adriamycin resistance in vitro and in vivo by calcium influx blockers.

Authors:  T Tsuruo; H Iida; M Nojiri; S Tsukagoshi; Y Sakurai
Journal:  Cancer Res       Date:  1983-06       Impact factor: 12.701

6.  Effects of vinblastine, colchicine, and verapamil on rhodamine 123 accumulation in human P-glycoprotein-positive leukemia cells.

Authors:  D Lautier; Y Canitrot; J M Salmon
Journal:  Anticancer Res       Date:  1994 Nov-Dec       Impact factor: 2.480

7.  Early steps of the P-glycoprotein expression in cell cultures studied with vital fluorochrome.

Authors:  S V Egudina; T P Stromskaya; E A Frolova; A A Stavrovskaya
Journal:  FEBS Lett       Date:  1993-08-23       Impact factor: 4.124

8.  P-glycoprotein in the blood-brain barrier of mice influences the brain penetration and pharmacological activity of many drugs.

Authors:  A H Schinkel; E Wagenaar; C A Mol; L van Deemter
Journal:  J Clin Invest       Date:  1996-06-01       Impact factor: 14.808

9.  Cell surface P-glycoprotein associated with multidrug resistance in mammalian cell lines.

Authors:  N Kartner; J R Riordan; V Ling
Journal:  Science       Date:  1983-09-23       Impact factor: 47.728

10.  Age-dependent expression of P-glycoprotein gp170 in Caco-2 cell monolayers.

Authors:  K I Hosoya; K J Kim; V H Lee
Journal:  Pharm Res       Date:  1996-06       Impact factor: 4.200

View more
  5 in total

Review 1.  Functional expression and localization of P-glycoprotein in the central nervous system: relevance to the pathogenesis and treatment of neurological disorders.

Authors:  Gloria Lee; Reina Bendayan
Journal:  Pharm Res       Date:  2004-08       Impact factor: 4.200

Review 2.  In vitro models of the blood-brain barrier: An overview of commonly used brain endothelial cell culture models and guidelines for their use.

Authors:  Hans C Helms; N Joan Abbott; Malgorzata Burek; Romeo Cecchelli; Pierre-Olivier Couraud; Maria A Deli; Carola Förster; Hans J Galla; Ignacio A Romero; Eric V Shusta; Matthew J Stebbins; Elodie Vandenhaute; Babette Weksler; Birger Brodin
Journal:  J Cereb Blood Flow Metab       Date:  2016-02-11       Impact factor: 6.200

3.  Paclitaxel succinate analogs: Anionic and amide introduction as a strategy to impart blood-brain barrier permeability.

Authors:  Brandon J Turunen; Haibo Ge; Jariat Oyetunji; Kelly E Desino; Veena Vasandani; Sarah Güthe; Richard H Himes; Kenneth L Audus; Anna Seelig; Gunda I Georg
Journal:  Bioorg Med Chem Lett       Date:  2008-10-02       Impact factor: 2.823

4.  (3R,5S,7as)-(3,5-Bis(4-fluorophenyl)tetrahydro-1H-oxazolo[3,4-c]oxazol-7a-yl)methanol, a novel neuroprotective agent.

Authors:  Kelly E Desino; Sabah Ansar; Gunda I Georg; Richard H Himes; Mary Lou Michaelis; Douglas R Powell; Emily A Reiff; Hanumaiah Telikepalli; Kenneth L Audus
Journal:  J Med Chem       Date:  2009-12-10       Impact factor: 7.446

5.  Overcoming the blood-brain barrier to taxane delivery for neurodegenerative diseases and brain tumors.

Authors:  Antonie Rice; Mary L Michaelis; Gunda Georg; Yanbin Liu; Brandon Turunen; Kenneth L Audus
Journal:  J Mol Neurosci       Date:  2003       Impact factor: 2.866

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.